|
Brzozowski AM, Savage H, Verma CS, Turkenburg JP, Lawson DM, Svendsen A, Patkar S. 2000. Structural origins of the interfacial activation in Thermomyces (Humicola) lanuginosa lipase. Biochemistry 39(49):15071-82.
Clackson T, Hoogenboom HR, Griffiths AD, Winter G. 1991. Making antibody fragments using phage display libraries. Nature 352(6336):624-8.
Danielsen S, Eklund M, Deussen HJ, Graslund T, Nygren PA, Borchert TV. 2001. In vitro selection of enzymatically active lipase variants from phage libraries using a mechanism-based inhibitor. Gene 272(1-2):267-74.
Deussen HJ, Danielsen S, Breinholt J, Borchert TV. 2000. Design and synthesis of triglyceride analogue biotinylated suicide inhibitors for directed molecular evolution of lipolytic enzymes. Bioorg Med Chem Lett 10(17):2027-31.
Deussen HJ, Danielsen S, Breinholt J, Borchert TV. 2000. A novel biotinylated suicide inhibitor for directed molecular evolution of lipolytic enzymes. Bioorg Med Chem 8(3):507-13.
Diamandis EP, Christopoulos TK. 1991. The biotin-(strept)avidin system: principles and applications in biotechnology. Clin Chem 37(5):625-36.
Diamandis EP, Christopoulos TK. 1991. The biotin-(strept)avidin system: principles and applications in biotechnology. Clin Chem 37(5):625-36.
Ferrer M, Cruces MA, Bernabe M, Ballesteros A, Plou FJ. 1999. Lipase-catalyzed regioselective acylation of sucrose in two-solvent mixtures. Biotechnol Bioeng 65(1):10-6.
Gilham D, Lehner R. 2005. Techniques to measure lipase and esterase activity in vitro. Methods 36(2):139-47.
Gonzalez M, Bagatolli LA, Echabe I, Arrondo JL, Argarana CE, Cantor CR, Fidelio GD. 1997. Interaction of biotin with streptavidin. Thermostability and conformational changes upon binding. J Biol Chem 272(17):11288-94.
Landry DW, Zhao K, Yang GX, Glickman M, Georgiadis TM. 1993. Antibody-catalyzed degradation of cocaine. Science 259(5103):1899-901.
Lienhard GE. 1973. Enzymatic catalysis and transition-state theory. Science 180(82):149-54.
McCafferty J, Griffiths AD, Winter G, Chiswell DJ. 1990. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348(6301):552-4.
McCafferty J, Jackson RH, Chiswell DJ. 1991. Phage-enzymes: expression and affinity chromatography of functional alkaline phosphatase on the surface of bacteriophage. Protein Eng 4(8):955-61.
Miyashita H, Karaki Y, Kikuchi M, Fujii I. 1993. Prodrug activation via catalytic antibodies. Proc Natl Acad Sci U S A 90(11):5337-40.
Nissim, A., Hoogenboom, H. R., Tomlinson, I. M., Flynn, G., Midgley, C., Lane, D. and Winter, G. 1994. Antibody fragments from a 'single pot' phage display library as immunochemical reagents. EMBO J. 13:692-698.
Pauling L. 1948. Chemical achievement and hope for the future. Am Sci(36):51.
Pollack SJ, Jacobs, J.W., and Schultz, P.G. 1986. Selective chemical catalysis by an antibody. Science(243):1570.
Smith GP. 1985. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228(4705):1315-7.
Thomas NR. 1996. Catalytic antibodies—reaching adolescence? Nat Prod Rep 13:479.
Wentworth P, Datta A, Blakey D, Boyle T, Partridge LJ, Blackburn GM. 1996. Toward antibody-directed "abzyme" prodrug therapy, ADAPT: carbamate prodrug activation by a catalytic antibody and its in vitro application to human tumor cell killing. Proc Natl Acad Sci U S A 93(2):799-803.
Wentworth P, Jr., Liu Y, Wentworth AD, Fan P, Foley MJ, Janda KD. 1998. A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis. Proc Natl Acad Sci U S A 95(11):5971-5.
Wolfenden BGMaR. 2002. CATALYTIC PROFICIENCY: The Unusual Case of OMP Decarboxylase Annu Rev Biochem.(71):847-85.
|